Blood Cancer and the Heart: Light Chain Cardiomyopathy in Refractory Multiple Myeloma.

IF 0.6 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
Case Reports in Cardiology Pub Date : 2022-07-30 eCollection Date: 2022-01-01 DOI:10.1155/2022/7846846
Abdulbaril Olagunju, Chandana Shekar, Michael Morris, Anantharam Kalya, Farouk Mookadam, Samuel Unzek
{"title":"Blood Cancer and the Heart: Light Chain Cardiomyopathy in Refractory Multiple Myeloma.","authors":"Abdulbaril Olagunju,&nbsp;Chandana Shekar,&nbsp;Michael Morris,&nbsp;Anantharam Kalya,&nbsp;Farouk Mookadam,&nbsp;Samuel Unzek","doi":"10.1155/2022/7846846","DOIUrl":null,"url":null,"abstract":"<p><p>We report a case of a 57-year-old woman with a history of multiple myeloma (MM) and light chain (AL) amyloidosis who presented due to worsening dyspnea on exertion. Her MM has been refractory to multiple chemotherapy regimens and two autologous bone marrow transplantation. Diagnostic evaluations including serum kappa and lambda chains, echocardiogram, pyrophosphate cardiac scan, and cardiac magnetic resonance were indicative of a progression to AL cardiomyopathy. Addition of daratumumab to her regimen appeared to ameliorate the progression of AL cardiomyopathy. However, it was stopped due to adverse effects of pancytopenia and allergic reactions including skin rash and hives. She was hospitalized for heart failure exacerbation and died approximately 2 months following the discontinuation of daratumumab. This case highlights the late presentation of AL cardiomyopathy in refractory MM.</p>","PeriodicalId":51760,"journal":{"name":"Case Reports in Cardiology","volume":" ","pages":"7846846"},"PeriodicalIF":0.6000,"publicationDate":"2022-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356901/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/7846846","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 1

Abstract

We report a case of a 57-year-old woman with a history of multiple myeloma (MM) and light chain (AL) amyloidosis who presented due to worsening dyspnea on exertion. Her MM has been refractory to multiple chemotherapy regimens and two autologous bone marrow transplantation. Diagnostic evaluations including serum kappa and lambda chains, echocardiogram, pyrophosphate cardiac scan, and cardiac magnetic resonance were indicative of a progression to AL cardiomyopathy. Addition of daratumumab to her regimen appeared to ameliorate the progression of AL cardiomyopathy. However, it was stopped due to adverse effects of pancytopenia and allergic reactions including skin rash and hives. She was hospitalized for heart failure exacerbation and died approximately 2 months following the discontinuation of daratumumab. This case highlights the late presentation of AL cardiomyopathy in refractory MM.

Abstract Image

Abstract Image

Abstract Image

血癌与心脏:难治性多发性骨髓瘤的轻链心肌病。
我们报告一例57岁的女性多发性骨髓瘤(MM)和轻链(AL)淀粉样变病史,谁提出了由于恶化呼吸困难的运动。她的MM对多次化疗方案和两次自体骨髓移植都是难治性的。诊断评估包括血清kappa和lambda链,超声心动图,焦磷酸盐心脏扫描和心脏磁共振表明AL心肌病的进展。在她的治疗方案中加入达拉单抗似乎可以改善AL心肌病的进展。然而,由于全血细胞减少症的不良反应和过敏反应,包括皮疹和荨麻疹,它被停止了。她因心力衰竭加重住院,并在停止达拉单抗治疗约2个月后死亡。本病例强调难治性MM晚期AL型心肌病的表现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Case Reports in Cardiology
Case Reports in Cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
自引率
0.00%
发文量
63
审稿时长
13 weeks
期刊介绍: Case Reports in Cardiology is a peer-reviewed, Open Access journal that publishes case reports and case series related to hypertension, arrhythmia, congestive heart failure, valvular heart disease, vascular disease, congenital heart disease and cardiomyopathy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信